The group’s revenue rose 44.9% y-o-y to US$14.1 million for FY2024, from US$9.70 million in FY2023.
Pharmaceuticals and medical supplies company Pasture Holdings has reversed into earnings of US$559,000 ($731,490) for FY2024 ended June 30, compared to the US$1.26 million loss it reported in FY2023.
Earnings per share for FY2024 stood at 0.42 US cents, up from a loss per share of 1.15 US cents in the previous financial year.
